Advertisement

Topics

Baricitinib treatment yielded similar infection risk as other therapies for RA

14:53 EDT 3 Jul 2017 | Healio

In patients with active rheumatoid arthritis, treatment with baricitinib appeared to yield an incidence of serious infection events comparable to that incurred in placebo-treated patients, according to a study presented at the EULAR Annual Congress in Madrid.“The main finding is that the infection rate was similar to what we have seen with other [Janus kinase] JAK inhibitors, as well as biologics,” researcher Kevin L. Winthrop, MD, assistant professor at Oregon Health and Science University told Healio Rheumatology. “There is an increased risk of serious infection, but it is similar to that of other types of therapy used in [rheumatoid arthritis] RA.”

Original Article: Baricitinib treatment yielded similar infection risk as other therapies for RA

NEXT ARTICLE

More From BioPortfolio on "Baricitinib treatment yielded similar infection risk as other therapies for RA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...